EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Epigenetic regulation of DHRS2 by SUV420H2 inhibits cell apoptosis in renal cell carcinoma

Tae Young Ryu, Jinkwon Lee, Yunsang Kang, Mi-Young Son, Dae-Soo Kim, Youn Su Lee, Mi-Young Kim, Hyun-Soo Cho

Biochemical and Biophysical Research Communications · 2023-06 · 663 · 41-46

DOI: 10.1016/j.bbrc.2023.04.066 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biochemical and Biophysical Research Communications, 2023-06. Verfasst von Tae Young Ryu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Korea Advanced Institute of Science and Technology (KAIST), Department of Biological Science, Daejeon, 34141, Republic of Korea; Korea Research Insti…. Hauptthemen laut MEDLINE: Carcinoma, Renal Cell, Kidney Neoplasms. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 19 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Research Foundation of Korea, Ministry of Trade, Industry and Energy, Ministry of Science, ICT and Future Planning.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Renal cell carcinoma (RCC), also known as kidney cancer, is a common malignant tumor of the urinary system. While surgical treatment is essential, novel therapeutic targets and corresponding drugs for RCC are still needed due to the high relapse rate and low five-year survival rate. In this study, we found that SUV420H2 is overexpressed in renal cancers and that high SUV420H2 expression is associated with a poor prognosis, as evidenced by RCC RNA-seq results derived from the TCGA. SUV420H2 knockdown using siRNA led to growth suppression and cell apoptosis in the A498 cell line. Furthermore, we identified DHRS2 as a direct target of SUV420H2 in the apoptosis process through a ChIP assay with a histone 4 lysine 20 (H4K20) trimethylation antibody. Rescue experiments showed that cotreatment with siSUV420H2 and siDHRS2 attenuated cell growth suppression induced by SUV420H2 knockdown only. Additionally, treatment with the SUV420H2 inhibitor A-196 induced cell apoptosis via upregulation of DHRS2. Taken together, our findings suggest that SUV420H2 may be a potential therapeutic target for the treatment of renal cancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Renal CellKidney NeoplasmsHumansEpigenesis, GeneticHistone-Lysine N-MethyltransferaseNeoplasm Recurrence, LocalApoptosisCell Line, TumorGene Expression Regulation, NeoplasticCell ProliferationCarbonyl Reductase (NADPH)

Stichwörter der Autor:innen

ApoptosisDHRS2Renal cell carcinomaSUV420H2

Substanzen

Histone-Lysine N-MethyltransferaseDHRS2 protein, humanCarbonyl Reductase (NADPH)

Autor:innen und Institutionen

  • Korea Advanced Institute of Science and Technology (KAIST), Department of Biological Science, Daejeon, 34141, Republic of Korea; Korea Research Institute of Bioscience and Biotechnology, Daejeon, 34141, Republic of Kore…
  • Korea Research Institute of Bioscience and Biotechnology, Daejeon, 34141, Republic of Korea; Korea University of Science and Technology, Daejeon, 34113, Republic of Korea.
  • Korea Research Institute of Bioscience and Biotechnology, Daejeon, 34141, Republic of Korea; Korea University of Science and Technology, Daejeon, 34113, Republic of Korea; Sungkyunkwan University, Department of Biologic…
  • RedGene Inc., Seoul, 08790, Republic of Korea.
  • Korea Advanced Institute of Science and Technology (KAIST), Department of Biological Science, Daejeon, 34141, Republic of Korea. Electronic address: miyoungkim@kaist.ac.kr.

Förderung

  • National Research Foundation of Korea
  • Ministry of Trade, Industry and Energy
  • Ministry of Science, ICT and Future Planning
  • Korea Research Institute of Bioscience and Biotechnology

Zitieren

APA

Ryu, T. Y., Lee, J., Kang, Y., Son, M. Y., Kim, D. S., Lee, Y. S., Kim, M. Y., & Cho, H. S. (2023). Epigenetic regulation of DHRS2 by SUV420H2 inhibits cell apoptosis in renal cell carcinoma. Biochemical and Biophysical Research Communications, 663, 41-46. https://doi.org/10.1016/j.bbrc.2023.04.066

Vancouver

Ryu TY, Lee J, Kang Y, Son MY, Kim DS, Lee YS, et al. Epigenetic regulation of DHRS2 by SUV420H2 inhibits cell apoptosis in renal cell carcinoma. Biochemical and Biophysical Research Communications. 2023;663:41-46. doi:10.1016/j.bbrc.2023.04.066

BibTeX
@article{Ryu2023,
  author = {Ryu, Tae Young and Lee, Jinkwon and Kang, Yunsang and Son, Mi-Young and Kim, Dae-Soo and Lee, Youn Su and Kim, Mi-Young and Cho, Hyun-Soo},
  title = {Epigenetic regulation of DHRS2 by SUV420H2 inhibits cell apoptosis in renal cell carcinoma},
  journal = {Biochemical and Biophysical Research Communications},
  year = {2023},
  volume = {663},
  pages = {41--46},
  doi = {10.1016/j.bbrc.2023.04.066}
}
Kostenlos starten →